explore -WSS

explore

author：focus 2025-08-11 07:59:20 - browse：35353

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： FDA official pushes for dedicated emerging pathogens team

WSS

CDC backtracks, saying fully vaccinated people can go maskless indoors

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Review: 'Barbie' will hit you like a shot in the heart

Couple fighting to bring baby home from Mexico are finally reunited

Why an extreme heat and wildfire smoke combination can be so dangerous

As Taiwan prepares for anti

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

What does generative AI mean for health care? We asked experts

Why an extreme heat and wildfire smoke combination can be so dangerous

Sports medicine is finally prioritizing gender equality

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

What does generative AI mean for health care? We asked experts

Why some people catch Covid but never get sick

Tori Bowie and the unacceptable rates of Black maternal death

CDC backtracks, saying fully vaccinated people can go maskless indoors

Anesthesiologist group: stop taking Ozempic before surgery

Seattle police shoot person suspected in downtown stabbing

focus

DOJ, FTC to increase scrutiny of all types of health care mergers

'Reaching a detente': STAT's Helen Branswell on covering Covid

HIPAA doesn't protect reproductive records from prosecutors

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Our daughter's deadly disease: trisomy 18. We wanted to protect her

focus

explore

focus

knowledge